CRISPR/Cas9 gene editing for curing sickle cell disease. | Transfus Apher Sci;60(1): 103060, 2021 Feb. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

Nursing VHL Search Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

CRISPR/Cas9 gene editing for curing sickle cell disease.

Park, So Hyun; Bao, Gang.

Affiliation

Park SH; Department of Bioengineering, Rice University, 6500 Main St, Houston, TX, 77030, USA. Electronic address: shp9n@virginia.edu.
Bao G; Department of Bioengineering, Rice University, 6500 Main St, Houston, TX, 77030, USA. Electronic address: gang.bao@rice.edu.

Transfus Apher Sci ; 60(1): 103060, 2021 Feb.

Article in En | MEDLINE | ID: mdl-33455878

Subject(s)

Anemia, Sickle Cell/therapy; CRISPR-Cas Systems/genetics; Gene Editing/methods; Humans

Key words

CRISPR/Cas9; Gene editing; Sickle cell disease

Search on Google

Full text: 1 Database: MEDLINE Main subject: CRISPR-Cas Systems / Gene Editing / Anemia, Sickle Cell Limits: Humans Language: En Journal: Transfus Apher Sci Journal subject: HEMATOLOGIA Year: 2021 Type: Article

Search on Google

Full text: 1 Database: MEDLINE Main subject: CRISPR-Cas Systems / Gene Editing / Anemia, Sickle Cell Limits: Humans Language: En Journal: Transfus Apher Sci Journal subject: HEMATOLOGIA Year: 2021 Type: Article